Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic-Assisted Surgery for Prostatectomy

By HospiMedica staff writers
Posted on 09 Nov 2004
A new study has shown that male patients who had a radical prostatectomy performed by surgeons with a surgical robot had the same outcomes as open surgery, but with less blood loss, shorter hospital stay, faster recovery, and minimal use of narcotics during recovery.

The study involved 300 men who had the procedure performed at the Urology Centers of Alabama (Birmingham, USA). More...
Average blood loss was less than 50 ml, which is less than the amount lost during standard open surgery. The men were hospitalized for one day following the operation, compared to two-three days of hospital stay after conventional surgery. Return to independent activities of daily living was seven to 10 days after the procedure, versus four to six weeks for traditional open surgery. In addition, up to 80% of the men did not consume any narcotic medication during their perioperative period.

The robotic system used in the study was the daVinci system (Intuitive Surgical, Sunnyvale, CA, USA). Its use increases precision and makes suturing easier, noted Dr. Vipul Patel, director of minimally invasive surgery at Urology Centers of Alabama. "Robotic prostatectomy makes a good surgeon even better because it enhances what you can do. It improves your ability to see the surgical field and allows increased surgical precision. This is important when attempting to remove the prostate while preserving the delicate nerves necessary for continence and potency.”

According to Dr. Patel, the demand for robotic-assisted radical prostatectomy is growing. He and his colleagues now perform eight to 10 procedures a week. Patients come from all over the world. "It definitely has the potential to become a standard of care in the future,” he added. The findings of the study were presented at the annual Clinical Congress of the American College of Surgeons (ACS) in New Orleans (LA, USA) in October 2004.




Related Links:
Intuitive Surgical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.